Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam D Cohen

Showing results (31-40 of 108) with videos related to

Pageof 11
Sort By:
Cancer Research|April 9, 2009
Immune rejection of mouse tumors expressing mutated selfFei Duan, Yun Lin, Cailian Liu, et al.
The Journal of Clinical Investigation|April 15, 2006
Optimization of a self antigen for presentation of multiple epitopes in cancer immunityJosé A Guevara-Patiño, Manuel E Engelhorn, Mary Jo Turk, et al.
Plos One|July 7, 2011
Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscopeDavid A Schaer, Yongbiao Li, Taha Merghoub, et al.
Oncoimmunology|August 17, 2017
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptorsAlexander W MacFarlane, Mowafaq Jillab, Mitchell R Smith, et al.
Cancers|January 13, 2021
Alterations of NK Cell Phenotype in the Disease Course of Multiple MyelomaTatiana Pazina, Alexander W MacFarlane, Luca Bernabei, et al.
JAMA Oncology|December 30, 2017
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysisAdam J Waxman, Suparna Clasen, Wei-Ting Hwang, et al.
European Journal of Haematology|December 5, 2022
Progressive multifocal leukoencephalopathy in multiple myelomaBrian W Hoeynck, Adam D Cohen, Edward A Stadtmauer, et al.
Oncoimmunology|September 22, 2017
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanismsTatiana Pazina, Ashley M James, Alexander W MacFarlane, et al.
Oncology and Therapy|April 4, 2023
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple MyelomaSundar Jagannath, Nedra Joseph, Concetta Crivera, et al.
Cancer Research|May 3, 2006
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityAdam D Cohen, Adi Diab, Miguel-Angel Perales, et al.
Pageof 11

Showing results (31-40 of 108) with videos related to

Sort By:
Pageof 11
Cancer Research|April 9, 2009
Immune rejection of mouse tumors expressing mutated selfFei Duan, Yun Lin, Cailian Liu, et al.
The Journal of Clinical Investigation|April 15, 2006
Optimization of a self antigen for presentation of multiple epitopes in cancer immunityJosé A Guevara-Patiño, Manuel E Engelhorn, Mary Jo Turk, et al.
Plos One|July 7, 2011
Detection of intra-tumor self antigen recognition during melanoma tumor progression in mice using advanced multimode confocal/two photon microscopeDavid A Schaer, Yongbiao Li, Taha Merghoub, et al.
Oncoimmunology|August 17, 2017
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptorsAlexander W MacFarlane, Mowafaq Jillab, Mitchell R Smith, et al.
Cancers|January 13, 2021
Alterations of NK Cell Phenotype in the Disease Course of Multiple MyelomaTatiana Pazina, Alexander W MacFarlane, Luca Bernabei, et al.
JAMA Oncology|December 30, 2017
Carfilzomib-Associated Cardiovascular Adverse Events: A Systematic Review and Meta-analysisAdam J Waxman, Suparna Clasen, Wei-Ting Hwang, et al.
European Journal of Haematology|December 5, 2022
Progressive multifocal leukoencephalopathy in multiple myelomaBrian W Hoeynck, Adam D Cohen, Edward A Stadtmauer, et al.
Oncoimmunology|September 22, 2017
The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanismsTatiana Pazina, Ashley M James, Alexander W MacFarlane, et al.
Oncology and Therapy|April 4, 2023
Component Costs of CAR-T Therapy in Addition to Treatment Acquisition Costs in Patients with Multiple MyelomaSundar Jagannath, Nedra Joseph, Concetta Crivera, et al.
Cancer Research|May 3, 2006
Agonist anti-GITR antibody enhances vaccine-induced CD8(+) T-cell responses and tumor immunityAdam D Cohen, Adi Diab, Miguel-Angel Perales, et al.
Pageof 11